From October 1, 2022 to December 31, 2022, the company has repurchased 4,000 shares, representing 0.009061% for ¥8.97 million. With this, the company has completed the repurchase of 203,900 shares, representing 0.46% for ¥419.21 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,113 JPY | +0.14% |
|
+2.67% | +4.76% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.76% | 579M | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.